Sign Out
In patients with respiratory depression, dementia, psychotic diseases or hepatic insufficiency.
Apomorphine HCl treatment must not be administered to patients who have an 'on' response to levodopa, which is marred by severe dyskinesia or dystonia.
APO-go should not be administered to patients who have a known hypersensitivity to apomorphine or any of the excipients of the medicinal product.
APO-go is contra-indicated for children and adolescents under 18 years of age.
